Sign Out
Hypersensitivity to ticagrelor or any component of the formulation.
Active pathological bleeding (e.g., peptic ulcer, intracranial hemorrhage).
History of intracranial hemorrhage.
Severe hepatic impairment.
UserName
Profession Email
Profession Email
Continue with Google